This is a preview of subscription content, log in via an institution to check access.
Notes
American Association for the Study of Liver Diseases
Reference
Corey KE, et al. Screening for Nonalcoholic Steatohepatitis in Individuals with Type 2 Diabetes: A Cost-Effectiveness Analysis. Digestive Diseases and Sciences : 29 Jan 2016. Available from: URL: http://doi.org/10.1007/s10620-016-4044-2
Rights and permissions
About this article
Cite this article
Is screening for NASH in type 2 DM cost effective?. PharmacoEcon Outcomes News 746, 24 (2016). https://doi.org/10.1007/s40274-016-2802-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-2802-1